Map kinase signaling pathways and hematologic malignancies
Data up to Jan 2025
Total Citations Per Year
Abstract
References (222)
Interleukin-10 and the Interleukin-10 Receptor
2001 • 6,422 citations
Mammalian MAP kinase signalling cascades
2001 • 5,041 citations
Signal Transduction by the JNK Group of MAP Kinases
2000 • 4,096 citations
Vascular endothelial growth factor (VEGF) and its receptors
1999 • 3,498 citations
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
1994 • 3,285 citations
JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain
1994 • 3,219 citations
A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
1994 • 2,659 citations
Mitogen-activated protein kinase pathways
1997 • 2,513 citations
Small GTP-Binding Proteins
2001 • 2,449 citations
Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways
1997 • 2,284 citations
Induction of Chronic Myelogenous Leukemia in Mice by the P210 bcr/abl Gene of the Philadelphia Chromosome
1990 • 2,207 citations
ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF
1991 • 1,901 citations
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
1988 • 1,698 citations
A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins
1994 • 1,684 citations
Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22
1984 • 1,644 citations
MAP Kinases in the Immune Response
2002 • 1,620 citations
Mitogen-Activated Protein Kinases: Specific Messages from Ubiquitous Messengers
1999 • 1,593 citations
The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.
2001 • 1,520 citations
Selective interaction of JNK protein kinase isoforms with transcription factors.
1996 • 1,333 citations
Identification of a Member of the MAPKKK Family as a Potential Mediator of TGF-β Signal Transduction
1995 • 1,318 citations
Raf-1 activates MAP kinase-kinase
1992 • 1,308 citations
Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene Products
1990 • 1,305 citations
Sounding the Alarm: Protein Kinase Cascades Activated by Stress and Inflammation
1996 • 1,099 citations
Differential Activation of ERK and JNK Mitogen-Activated Protein Kinases by Raf-1 and MEKK
1994 • 1,092 citations
A Divergence in the MAP Kinase Regulatory Network Defined by MEK Kinase and Raf
1993 • 1,086 citations
Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun
1994 • 978 citations
TNF-α Induction by LPS Is Regulated Posttranscriptionally via a Tpl2/ERK-Dependent Pathway
2000 • 785 citations
Ras and Rho GTPases
2000 • 779 citations
Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6
1989 • 775 citations
Phase I Trial of the Proteasome Inhibitor PS-341 in Patients With Refractory Hematologic Malignancies
2002 • 771 citations
Rho family proteins: coordinating cell responses
2001 • 763 citations
Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process
1998 • 761 citations
MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis
1999 • 744 citations
Characterization of the Structure and Function of a New Mitogen-activated Protein Kinase (p38β)
1996 • 744 citations
Rho Family GTPases Regulate p38 Mitogen-activated Protein Kinase through the Downstream Mediator Pak1
1995 • 733 citations
The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications
2003 • 721 citations
Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1
1994 • 706 citations
An Insulin-Stimulated Protein Kinase Similar to Yeast Kinases Involved in Cell Cycle Control
1990 • 701 citations
Activation of Mitogen-Activated Protein Kinase Kinase by v-Raf in NIH 3T3 Cells and in Vitro
1992 • 691 citations
A Cytoplasmic Inhibitor of the JNK Signal Transduction Pathway
1997 • 678 citations
Components of a New Human Protein Kinase Signal Transduction Pathway
1995 • 644 citations
TAB1: An Activator of the TAK1 MAPKKK in TGF-β Signal Transduction
1996 • 582 citations
Mixed-lineage kinase control of JNK and p38 MAPK pathways
2002 • 556 citations
Interleukin-6 in human multiple myeloma
1995 • 550 citations
Requirement for MAP Kinase (ERK2) Activity in Interferon α- and Interferon β-Stimulated Gene Expression Through STAT Proteins
1995 • 549 citations
Selective Activation of p38 Mitogen-activated Protein (MAP) Kinase Isoforms by the MAP Kinase Kinases MKK3 and MKK6
1998 • 531 citations
Small GTP-Binding Proteins
1992 • 526 citations
The Pathophysiology of Acquired Aplastic Anemia
1997 • 522 citations
Essential Role of p38α MAP Kinase in Placental but Not Embryonic Cardiovascular Development
2000 • 509 citations
Novel Homologues of CSBP/p38 MAP Kinase: Activation, Substrate Specificity and Sensitivity to Inhibition by Pyridinyl Imidazoles
1997 • 504 citations
Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.
1989 • 501 citations
Characterization of the Structure and Function of the Fourth Member of p38 Group Mitogen-activated Protein Kinases, p38δ
1997 • 482 citations
Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model.
2002 • 462 citations
Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial
2001 • 458 citations
Signal transduction by tumor necrosis factor mediated by JNK protein kinases.
1994 • 456 citations
Pharmacological inhibitors of MAPK pathways
2002 • 437 citations
New Insights into the Control of MAP Kinase Pathways
1999 • 431 citations
Docking domains and substrate-specificity determination for MAP kinases
2000 • 430 citations
Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases
1997 • 424 citations
Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration
2001 • 420 citations
IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.
1997 • 416 citations
MAPK-regulated transcription: a continuously variable gene switch?
2002 • 404 citations
Acute promyelocytic leukemia: evolving therapeutic strategies
2002 • 399 citations
The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation.
1995 • 399 citations
The Primary Structure of p38γ: A New Member of p38 Group of MAP Kinases
1996 • 393 citations
Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
1983 • 373 citations
Essential role for p38α mitogen-activated protein kinase in placental angiogenesis
2000 • 370 citations
Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappaB
2002 • 369 citations
Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes.
1988 • 367 citations
Primary Structure of BMK1: A New Mammalian MAP Kinase
1995 • 345 citations
Requirement for p38α in Erythropoietin Expression
2000 • 343 citations
Signaling from the Small GTP-binding Proteins Rac1 and Cdc42 to the c-Jun N-terminal Kinase/Stress-activated Protein Kinase Pathway
1996 • 340 citations
ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation.
1996 • 331 citations
Role of MEKK1 in Cell Survival and Activation of JNK and ERK Pathways Defined by Targeted Gene Disruption
1998 • 322 citations
MLK-3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6.
1996 • 314 citations
Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia
2001 • 311 citations
Crystal Structures of MAP Kinase p38 Complexed to the Docking Sites on Its Nuclear Substrate MEF2A and Activator MKK3b
2002 • 309 citations
Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase.
1996 • 308 citations
Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma
2002 • 302 citations
Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?
2000 • 300 citations
Constitutive Activation of NF-κB Causes Resistance to Apoptosis in Human Cutaneous T Cell Lymphoma HuT-78 Cells
1998 • 300 citations
Interleukin-6 Inhibits Fas-Induced Apoptosis and Stress-Activated Protein Kinase Activation in Multiple Myeloma Cells
1997 • 278 citations
Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma
1995 • 275 citations
Actions of Rho Family Small G Proteins and p21-Activated Protein Kinases on Mitogen-Activated Protein Kinase Family Members
1996 • 275 citations
Deficiency of the Stress Kinase P38α Results in Embryonic Lethality
2000 • 272 citations
Signaling pathways activated by interferons
1999 • 268 citations
Perspectives on the development of a molecularly targeted agent
2002 • 267 citations
Primary Myeloma Cells Growing in SCID-hu Mice: A Model for Studying the Biology and Treatment of Myeloma and Its Manifestations
1998 • 261 citations
Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest.
1998 • 254 citations
Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cδ
2002 • 253 citations
The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia
2002 • 249 citations
The Nature of the 660-Kilometer Upper-Mantle Seismic Discontinuity from Precursors to the PP Phase
1996 • 245 citations
The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses.
2000 • 242 citations
MEK kinase 1 gene disruption alters cell migration and c-Jun NH 2 -terminal kinase regulation but does not cause a measurable defect in NF-κB activation
2000 • 240 citations
Mutations in N-ras predominate in acute myeloid leukemia
1987 • 239 citations
Interleukin 6 is essential for in vivo development of B lineage neoplasms.
1995 • 233 citations
Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial
1996 • 229 citations
Chronic myeloid leukemia: current treatment options
2001 • 229 citations
The Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to-S phase transition in hematopoietic cells
1997 • 228 citations
Molecular Cloning of Mitogen-activated Protein/ERK Kinase Kinases (MEKK) 2 and 3
1996 • 227 citations
Activation of the p38 Mitogen-activated Protein Kinase by Type I Interferons
1999 • 226 citations
The chimeric anti-CD20 antibody rituximab induces apoptosis in B-cell chronic lymphocytic leukemia cells through a p38 mitogen activated protein–kinase–dependent mechanism
2002 • 225 citations
The Mixed Lineage Kinase SPRK Phosphorylates and Activates the Stress-activated Protein Kinase Activator, SEK-1
1996 • 221 citations
Thrombopoietin-Induced Activation of the Mitogen-Activated Protein Kinase (MAPK) Pathway in Normal Megakaryocytes: Role in Endomitosis
1999 • 212 citations
Granulocyte-macrophage colony-stimulating factor, interleukin-3, and steel factor induce rapid tyrosine phosphorylation of p42 and p44 MAP kinase
1992 • 210 citations
Activation of p38 MAP Kinase and JNK But Not ERK Is Required for Erythropoietin-Induced Erythroid Differentiation
1998 • 205 citations
Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection
2000 • 205 citations
Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
2002 • 197 citations
Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways
2000 • 197 citations
Studies of interferon as a regulator of hematopoietic cell proliferation.
1985 • 195 citations
The Rac1/p38 Mitogen-activated Protein Kinase Pathway Is Required for Interferon α-dependent Transcriptional Activation but Not Serine Phosphorylation of Stat Proteins
2000 • 195 citations
Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines
1996 • 190 citations
Signaling pathways activated by daunorubicin
2001 • 182 citations
p38-2, a Novel Mitogen-activated Protein Kinase with Distinct Properties
1997 • 176 citations
Granulocyte-macrophage colony-stimulating factor, interleukin-3, and steel factor induce rapid tyrosine phosphorylation of p42 and p44 MAP kinase
1992 • 176 citations
Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways
2000 • 175 citations
Untying the regulation of the Raf-1 kinase
2002 • 174 citations
Dexamethasone induces apoptosis of multiple myeloma cells in a JNK/SAP kinase independent mechanism
1997 • 174 citations
Effect of recombinant interferons alpha and gamma on human bone marrow- derived megakaryocytic progenitor cells
1987 • 173 citations
Hemopoietic Growth Factors with the Exception of Interleukin-4 Activate the p38 Mitogen-activated Protein Kinase Pathway
1997 • 172 citations
Insulin-like growth factor I is a dual effector of multiple myeloma cell growth
2000 • 171 citations
Kotlyarov, A. et al. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat. Cell Biol. 1, 94-97
1999 • 170 citations
Activation of the p38 Mitogen-activated Protein Kinase Mediates the Suppressive Effects of Type I Interferons and Transforming Growth Factor-β on Normal Hematopoiesis
2002 • 166 citations
Survival signaling mediated by c-Jun NH2-terminal kinase in transformed B lymphoblasts
2002 • 161 citations
Activation of Rac1 and the p38 Mitogen-activated Protein Kinase Pathway in Response to All-trans-retinoic Acid
2001 • 160 citations
SAP kinase‐3, a new member of the family of mammalian stress‐activated protein kinases
1996 • 159 citations
The p38 mitogen-activated protein kinase pathway and its role in interferon signaling
2003 • 155 citations
Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines
2002 • 153 citations
The Extracellular Signal-Regulated Kinase Pathway Phosphorylates AML1, an Acute Myeloid Leukemia Gene Product, and Potentially Regulates Its Transactivation Ability
1996 • 153 citations
Insulinlike growth factor–I signaling in multiple myeloma: downstream elements, functional correlates, and pathway cross-talk
2002 • 152 citations
Extracellular Signal-Regulated Kinase 7 (ERK7), a Novel ERK with a C-Terminal Domain That Regulates Its Activity, Its Cellular Localization, and Cell Growth
1999 • 152 citations
Involvement of protein kinase C and phosphatidylinositol 3–kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells
2002 • 149 citations
TCR and CD28 Are Coupled Via ZAP-70 to the Activation of the Vav/Rac-1-/PAK-1/p38 MAPK Signaling Pathway
1999 • 148 citations
Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells
1997 • 147 citations
Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon.
1993 • 145 citations
The p38 MAPK Pathway Mediates the Growth Inhibitory Effects of Interferon-α in BCR-ABL-expressing Cells
2001 • 143 citations
Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia
2000 • 143 citations
Synergistic Activation of MAP Kinase (ERK1/2) by Erythropoietin and Stem Cell Factor Is Essential for Expanded Erythropoiesis
1998 • 141 citations
Dual Leucine Zipper-bearing Kinase (DLK) Activates p46SAPK and p38 but Not ERK2
1996 • 140 citations
Activation of the phosphatidylinositol 3-kinase serine kinase by IFN-alpha.
1997 • 137 citations
MAP Kinase Signaling Specificity
2002 • 136 citations
Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR–ABL tyrosine kinase, CGP 57148
1998 • 134 citations
Functional expression of receptor activator of nuclear factor κB in Hodgkin disease cell lines
2001 • 133 citations
Constitutive Activation of Extracellular Signal-Regulated Kinase in Human Acute Leukemias: Combined Role of Activation of MEK, Hyperexpression of Extracellular Signal-Regulated Kinase, and Downregulation of a Phosphatase, PAC1
1999 • 132 citations
Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias
1993 • 131 citations
Cell-cycle–dependent activation of mitogen-activated protein kinase kinase (MEK-1/2) in myeloid leukemia cell lines and induction of growth inhibition and apoptosis by inhibitors of RAS signaling
2001 • 127 citations
Regulation of MAP kinases by docking domains
2001 • 127 citations
Activation of Rac1 and the p38 Mitogen-activated Protein Kinase Pathway in Response to Arsenic Trioxide
2002 • 125 citations
ERK8, a New Member of the Mitogen-activated Protein Kinase Family
2002 • 125 citations
Synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia
2002 • 121 citations
Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieu
2002 • 120 citations
Blast crisis in a murine model of chronic myelogenous leukemia.
1991 • 119 citations
A role for insulin-like growth factor in the regulation of IL-6-responsive human myeloma cell line growth.
1997 • 117 citations
Signal transduction by MAP kinases in T lymphocytes
2001 • 117 citations
Interleukin-6–Induced Inhibition of Multiple Myeloma Cell Apoptosis: Support for the Hypothesis That Protection Is Mediated Via Inhibition of the JNK/SAPK Pathway
1998 • 113 citations
Activation of JNK Signaling Pathway by Erythropoietin, Thrombopoietin, and Interleukin-3
1997 • 110 citations
Constitutive Activation of Extracellular Signal-Regulated Kinase in Human Acute Leukemias: Combined Role of Activation of MEK, Hyperexpression of Extracellular Signal-Regulated Kinase, and Downregulation of a Phosphatase, PAC1
1999 • 110 citations
Signaling Pathways Activated by Oncogenic Forms of Abl Tyrosine Kinase
1999 • 106 citations
c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for mitoxantrone- and anisomycin-induced apoptosis in HL-60 cells
2002 • 106 citations
Adriamycin activates c-jun N-terminal kinase in human leukemia cells: a relevance to apoptosis
1996 • 104 citations
Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma.
1995 • 103 citations
Genome-wide expression changes induced by HTLV-1 Tax: evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-κB activation
2001 • 101 citations
Cutting Edge: Activation of the p38 Mitogen-Activated Protein Kinase Signaling Pathway Mediates Cytokine-Induced Hemopoietic Suppression in Aplastic Anemia
2002 • 98 citations
Distinct Signaling from Stem Cell Factor and Erythropoietin in HCD57 Cells
1997 • 98 citations
JNK and p38 are activated by erythropoietin (EPO) but are not induced in apoptosis following EPO withdrawal in EPO-dependent HCD57 cells
2000 • 96 citations
The roles of signaling by the p42/p44 mitogen-activated protein (MAP) kinase pathway; a potential route to radio- and chemo-sensitization of tumor cells resulting in the induction of apoptosis and loss of clonogenicity
1998 • 94 citations
The inhibition of ERK/MAPK not the activation of JNK/SAPK is primarily required to induce apoptosis in chronic myelogenous leukemic K562 cells
2000 • 94 citations
Combined treatment with the checkpoint abrogator UCN-01 and MEK1/2 inhibitors potently induces apoptosis in drug-sensitive and -resistant myeloma cells through an IL-6–independent mechanism
2002 • 94 citations
Constitutively activated JNK is associated with HTLV-1 mediated tumorigenesis.
1996 • 92 citations
Evidence for Involvement of Mitogen-Activated Protein Kinase, Rather than Stress-Activated Protein Kinase, in Potentiation of 1-β-d-Arabinofuranosylcytosine-Induced Apoptosis by Interruption of Protein Kinase C Signaling
1998 • 90 citations
Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism
2000 • 90 citations
Activation of p38 MAP Kinase Pathway by Erythropoietin and Interleukin-3
1997 • 89 citations
The Epstein–Barr Virus Latent Membrane Protein 1 Induces Interleukin-10 in Burkitt's Lymphoma Cells but Not in Hodgkin's Cells Involving the p38/SAPK2 Pathway
2001 • 85 citations
Interleukin-6 dependence of advanced malignant plasma cell dyscrasias
1992 • 82 citations
Activation of the Stress-Activated Protein Kinases by Multiple Hematopoietic Growth Factors With the Exception of Interleukin-4
1997 • 81 citations
Farnesyl transferase inhibitor R115777 induces apoptosis of human myeloma cells
2002 • 80 citations
Epstein-Barr Virus Latent Membrane Protein 2A Regulates c-Jun Protein through Extracellular Signal-Regulated Kinase
2002 • 80 citations
In vivo and in vitro inhibitory effect of α‐interferon on megakaryocyte colony growth in essential thrombocythaemia
1989 • 79 citations
The synergistic influence of human interferon-gamma and interferon-alpha on suppression of hematopoietic progenitor cells is additive with the enhanced sensitivity of these cells to inhibition by interferons at low oxygen tension in vitro.
1985 • 79 citations
Molecular aspects of multiple myeloma
2002 • 76 citations
A conditionally-active form of MEK1 results in autocrine transformation of human and mouse hematopoietic cells
2000 • 76 citations
Sequence-Dependent Potentiation of Paclitaxel-Mediated Apoptosis in Human Leukemia Cells by Inhibitors of the Mitogen-Activated Protein Kinase Kinase/Mitogen-Activated Protein Kinase Pathway
2001 • 74 citations
The leukaemic oncoproteins Bcr-Abl and Tel-Abl (ETV6/Abl) have altered substrate preferences and activate similar intracellular signalling pathways
2000 • 74 citations
Guanine-Nucleotide Exchange Protein C3G Activates JNK1 by a Ras-independent Mechanism
1998 • 73 citations
Activation of p38 Mitogen-activated Protein Kinase Is Required for Tumor Necrosis Factor-α-supported Proliferation of Leukemia and Lymphoma Cell Lines
2000 • 72 citations
Cloning and characterization of p97MAPK, a novel human homolog of rat ERK-3.
1994 • 69 citations
CrkL Mediates Ras-dependent Activation of the Raf/ERK Pathway through the Guanine Nucleotide Exchange Factor C3G in Hematopoietic Cells Stimulated with Erythropoietin or Interleukin-3
1999 • 64 citations
p38 MAPK-mediated activation of NF-κB by the RhoGEF domain of Bcr
2002 • 62 citations
Cellular Proliferation and Activation of NFκB Are Induced by Autocrine Production of Tumor Necrosis Factor α in the Human T Lymphoma Line HuT 78
1995 • 60 citations
Role for c-jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-efflux and hyperproliferation
2002 • 58 citations
Requirement of thrombopoietin-induced activation of ERK for megakaryocyte differentiation and of p38 for erythroid differentiation
2001 • 55 citations
Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways cooperate in mediating cytokine-induced proliferation of a leukemic cell line
2002 • 53 citations
Complete Nucleotide Sequence, Expression, and Chromosomal Localisation of Human Mixed-Lineage Kinase 2
1995 • 52 citations
Targeted therapy for multiple myeloma
2001 • 48 citations
Combined effects of aberrant MEK1 activity and BCL2 overexpression on relieving the cytokine dependency of human and murine hematopoietic cells
2000 • 48 citations
Differential Activation of Two JNK Activators, MKK7 and SEK1, by MKN28-derived Nonreceptor Serine/Threonine Kinase/Mixed Lineage Kinase 2
1998 • 47 citations
Rac is activated by erythropoietin or interleukin-3 and is involved in activation of the Erk signaling pathway
2002 • 46 citations
Pharmacologically regulated cell therapy
2001 • 45 citations
Interferons
1995 • 43 citations
Mixed Lineage Kinase LZK Forms a Functional Signaling Complex with JIP-1, a Scaffold Protein of the c-Jun NH2-Terminal Kinase Pathway
2001 • 42 citations
Regulation of the c-jun Gene in p210 BCR-ABL Transformed Cells Corresponds With Activity of JNK, the c-jun N-Terminal Kinase
1998 • 41 citations
Lack of constitutive activation of MAP kinase pathway in human acute myeloid leukemia cells with N-Ras mutation
1999 • 40 citations
Signaling networks and cell cycle control : the molecular basis of cancer and other diseases
2000 • 39 citations
Signaling Via the Interferon-α Receptor in Chronic Myelogenous Leukemia Cells
2002 • 34 citations
The Roles of Phosphatidylinositol 3-Kinase and Protein Kinase Cζ for Thrombopoietin-induced Mitogen-activated Protein Kinase Activation in Primary Murine Megakaryocytes
2001 • 33 citations
Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?
2000 • 30 citations
Myeloid Leukemia Cell Growth and Differentiation Are Independent of Mitogen-activated Protein Kinase ERK1/2 Activation
2000 • 30 citations
A Thrombopoietin Receptor Mutant Deficient in Jak-STAT Activation Mediates Proliferation But Not Differentiation in UT-7 Cells
1999 • 30 citations
Functional interaction between retinoblastoma protein and stress-activated protein kinase in multiple myeloma cells.
1999 • 27 citations
Proliferation of IL‐6‐independent multiple myeloma does not require the activity of extracellular signal‐regulated kinases (ERK1/2)
2002 • 26 citations
Stress and Inflammation
1998 • 23 citations
Activation of Extracellular Signal-Regulated Kinase through B-Cell Antigen Receptor in B-Cell Chronic Lymphocytic Leukemia
2002 • 22 citations
The Protein Kinase ERK3 Is Encoded by a Single Functional Gene: Genomic Analysis of the ERK3 Gene Family
2002 • 21 citations
Risk assessment of venous thromboembolism in medical patients
2000 • 21 citations
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts.
2001 • 21 citations
Requirement for mitogen-activated protein kinase activation in the response of embryonic stem cell–derived hematopoietic cells to thrombopoietin in vitro
2002 • 19 citations
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts
2001 • 17 citations
Activation of p38 MAP Kinase and JNK But Not ERK Is Required for Erythropoietin-Induced Erythroid Differentiation
1998 • 14 citations
Influence of recombinant alpha and gamma interferons on the in vitro proliferation of myeloid and leukemic progenitors
1990 • 12 citations
Inhibition of MEK Induces Fas Expression and Apoptosis in Lymphomas Overexpressing Ras
2002 • 12 citations
Targeted therapy for multiple myeloma
2001 • 4 citations
Specific Inhibitors of p38 MAP Kinase
2003 • 3 citations